Published in Psychopharmacology (Berl) on March 16, 2012
Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment. Psychopharmacology (Berl) (2013) 0.82
DNA barcoding of Rhodiola (crassulaceae): a case study on a group of recently diversified medicinal plants from the Qinghai-Tibetan Plateau. PLoS One (2015) 0.82
The chemotaxonomic classification of Rhodiola plants and its correlation with morphological characteristics and genetic taxonomy. Chem Cent J (2013) 0.81
An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats. BMC Complement Altern Med (2014) 0.81
The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury. PLoS One (2014) 0.78
Rhodiola rosea Impairs Acquisition and Expression of Conditioned Place Preference Induced by Cocaine. Evid Based Complement Alternat Med (2013) 0.78
Noni (Morinda citrifolia Linn.) fruit juice attenuates the rewarding effect of ethanol in conditioned place preference in mice. Exp Anim (2016) 0.77
Rhodiola rosea L. extract and its active compound salidroside antagonized both induction and reinstatement of nicotine place preference in mice. Psychopharmacology (Berl) (2013) 0.76
Methanolic Extract of Morinda citrifolia L. (Noni) Unripe Fruit Attenuates Ethanol-Induced Conditioned Place Preferences in Mice. Front Pharmacol (2016) 0.75
Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol (2007) 4.78
Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci (1992) 4.57
Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23
Drug addiction. N Engl J Med (2003) 3.33
A range of research-based pharmacotherapies for addiction. Science (1997) 2.75
Molecular mechanisms of drug addiction. Neuropharmacology (2004) 2.69
Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol (2005) 2.47
Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev (1995) 2.17
The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev (2001) 2.11
Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev (2003) 1.93
A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev (2009) 1.80
The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend (1995) 1.65
Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine (2010) 1.55
Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev (2008) 1.48
Rhodiola rosea: a possible plant adaptogen. Altern Med Rev (2001) 1.32
The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biol Psychiatry (2002) 1.28
Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) (2005) 1.26
Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther (1993) 1.18
Corticotropin-releasing factor and behavior. Fed Proc (1985) 1.15
Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine (2000) 1.14
Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse (2009) 1.09
Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice. Psychopharmacology (Berl) (2006) 1.02
Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol (1993) 1.00
Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol (2009) 1.00
Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol (2009) 0.99
Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res (2007) 0.95
The neurobiology of addiction. J Neural Transm Suppl (2003) 0.94
Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res (2000) 0.94
Memantine blocks sensitization to the rewarding effects of morphine. Brain Res (2009) 0.90
The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine (2009) 0.89
Role of withdrawal in reinstatement of morphine-conditioned place preference. Psychopharmacology (Berl) (2005) 0.88
Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats. Indian J Exp Biol (2008) 0.88
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. Physiol Behav (2010) 0.88
Stress or drug priming induces reinstatement of extinguished conditioned place preference. Neuroreport (2000) 0.88
Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis. Med Hypotheses (2007) 0.88
Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol (2008) 0.88
Lesions of the medial prefrontal cortex prevent the acquisition but not reinstatement of morphine-induced conditioned place preference in mice. Neurosci Lett (2008) 0.87
Reinstatement of morphine-induced conditioned place preference in mice by priming injections. Neural Plast (2003) 0.86
Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. J Psychopharmacol (2007) 0.85
Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. Neuroreport (2000) 0.85
Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects. Biomed Environ Sci (2009) 0.83
The adaptogens rhodiola and schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol. Drug Target Insights (2007) 0.83
Effects of Papaver rhoeas extract on the acquisition and expression of morphine-induced conditioned place preference in mice. J Ethnopharmacol (2005) 0.82
Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. (Crassulaceae). Chem Pharm Bull (Tokyo) (1996) 0.82
Effects of a Rhodiola rosea L. extract on acquisition and expression of morphine tolerance and dependence in mice. J Psychopharmacol (2010) 0.82
Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn.--a brief perspective. Addict Biol (2003) 0.79
Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study. Neurotox Res (2009) 0.78
Effects of aqueous, methanolic and chloroform extracts of rhizome and aerial parts of Valeriana officinalis L. on naloxone-induced jumping in morphine-dependent mice. Addict Biol (2006) 0.78
Number of addictive substances used related to increased risk of unnatural death: a combined medico-legal and case-record study. BMC Psychiatry (2009) 0.78
Comparative study of Rhodiola preparations on behavioral despair of rats. Phytomedicine (2007) 0.78
Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol Biochem Behav (1996) 0.78
Effects of Coptis japonica on morphine-induced conditioned place preference in mice. Arch Pharm Res (2003) 0.77
Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice. J Psychopharmacol (2009) 0.77
[Effect of a Rhodiolae rosea extract on the level of inducible HSP-70 in the myocardium under stress]. Biull Eksp Biol Med (1996) 0.76
The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine. Phytother Res (2009) 0.75
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology (Berl) (2005) 1.15
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects. Eur J Pharmacol (2006) 0.92
Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem Behav (2003) 0.87
Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence. J Med Chem (2010) 0.86
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions. J Med Chem (2008) 0.86
Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats. Eur J Pharmacol (2002) 0.86
Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. J Psychopharmacol (2007) 0.85
Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? J Med Chem (2009) 0.85
Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane. J Med Chem (2010) 0.85
Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole. J Med Chem (2002) 0.82
Effects of a Rhodiola rosea L. extract on acquisition and expression of morphine tolerance and dependence in mice. J Psychopharmacol (2010) 0.82
Rhodiola rosea Impairs Acquisition and Expression of Conditioned Place Preference Induced by Cocaine. Evid Based Complement Alternat Med (2013) 0.78
Effects of Brugmansia arborea Extract and Its Secondary Metabolites on Morphine Tolerance and Dependence in Mice. Evid Based Complement Alternat Med (2012) 0.78
Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation. Neuroimmunomodulation (2003) 0.78
Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice. J Psychopharmacol (2009) 0.77
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. Bioorg Med Chem (2012) 0.76
Rhodiola rosea L. extract and its active compound salidroside antagonized both induction and reinstatement of nicotine place preference in mice. Psychopharmacology (Berl) (2013) 0.76
Synthesis, docking studies and anti-inflammatory activity of 4,5,6,7-tetrahydro-2H-indazole derivatives. Bioorg Med Chem (2007) 0.75
Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression. Neuroimmunomodulation (2004) 0.75